癌および他の疾患を治療および管理するための免疫調節性化合物を用いた方法および組成物

Title:

癌および他の疾患を治療および管理するための免疫調節性化合物を用いた方法および組成物

Document Type and Number:

Japanese Patent JP2005530784

Kind Code:

A

Abstract:

Methods of treating, preventing and/or managing cancer as well as diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.

More Like This:

WO/2001/012174	CYCLOBENZAPRINE FOR TREATING GENERALIZED ANXIETY DISORDER AND COMPOSITIONS THEREOF
JP2010524859	Activated PLGA nanoparticle formulation loaded with activator for targeted cancer nanotherapy
JP5202764	Alginate oligomers used to overcome multidrug resistance in bacteria

Inventors:

Zeldis, Jerome, Bee.

Application Number:

JP2004505051A

Publication Date:

October 13, 2005

Filing Date:

May 16, 2003

Export Citation:

Click for automatic bibliography generation Help

Assignee:

CELGENE CORPORATION

International Classes:

A61K45/00; A61K31/00; A61K31/198; A61K31/40; A61K31/4035; A61K31/425; A61K31/445; A61K31/454; A61K31/515; A61K31/573; A61K35/12; A61K35/14; A61K35/28; A61K45/06; A61K51/00; A61P1/04; A61P1/16; A61P3/06; A61P3/10; A61P7/02; A61P7/06; A61P9/00; A61P9/04; A61P9/10; A61P9/14; A61P11/00; A61P11/06; A61P11/16; A61P17/00; A61P17/02; A61P17/06; A61P17/10; A61P17/12; A61P19/02; A61P19/08; A61P19/10; A61P25/00; A61P27/02; A61P27/06; A61P27/10; A61P27/14; A61P29/00; A61P31/00; A61P31/04; A61P31/08; A61P31/10; A61P31/12; A61P31/18; A61P31/22; A61P33/00; A61P33/02; A61P33/06; A61P35/00; A61P35/02; A61P35/04; A61P37/00; A61P37/02; A61P37/06; A61P37/08; A61P41/00; A61P43/00; C07D209/46; C07D401/04; C07J5/00; (IPC1-7): A61K45/00; A61K31/198; A61K31/454; A61K31/573; A61K35/12; A61K35/14; A61K35/28; A61K45/06; A61K51/00; A61P1/04; A61P1/16; A61P3/10; A61P7/06; A61P9/00; A61P9/04; A61P9/10; A61P11/00; A61P11/06; A61P17/00; A61P17/02; A61P17/06; A61P17/12; A61P19/02; A61P19/10; A61P25/00; A61P27/02; A61P27/06; A61P29/00; A61P31/04; A61P31/08; A61P31/10; A61P31/12; A61P31/18; A61P31/22; A61P33/00; A61P33/06; A61P35/00; A61P35/04; A61P37/02; A61P37/06; A61P43/00; C07D401/04

Attorney, Agent or Firm:

Yusuke Hiraki
Ishii Teiji
Satoshi Fujita

Previous Patent: JP2005530783

Next Patent: 化合物、組成物、及び方法